The Latest Breaking News on Pharma

MSPs ask for update on Crown Office plans to bypass UK drug laws

MSPs have called for an update on the progress of plans to create safe drug consumption rooms in Scotland.

The National (Scotland) · Dec 13, 2022

Strep A outbreak: Everything we know as 19 children die of bacterial infection

Parents advised to be mindful of signs including characteristic rash and red tongue also known as ‘strawberry tongue’

The Independent UK · Dec 13, 2022

Strep A cases in your area as UK infections rise 30 per cent

Infections have been found around the country, as authorities warn parents to be vigilant

The Independent UK · Dec 13, 2022

Editorial: Mask, needle, health: Masks and vaccines are still our best shot to withstand a winter surge in respiratory infections

The clunky word “tripledemic” is now on many lips. It means we now face a winter with three different respiratory viruses with similar symptoms are spreading rapidly, and stressing hospital capacity.

Tribune News Service · Dec 13, 2022

Indonesia to produce Merck's HPV vaccines to combat cervical cancer

Indonesia will produce drugmaker Merck Co's vaccines for human papillomavirus (HPV), the chief of its state-owned pharmaceutical company Bio Farma said on Tuesday, in a bid to combat HPV-linked cervical cancer in the country.

Reuters · Dec 13, 2022

Japan's Meiji Holdings says drug unit started late-stage trial for COVID vaccine

Japan's Meiji Holdings Co said on Tuesday its drug subsidiary had started a Phase III trial of an mRNA-based vaccine for COVID-19.

Reuters · Dec 13, 2022

Shionogi says Japan government to buy 1 million more COVID pill doses

Shionogi Co Ltd said on Tuesday the Japanese government agreed to purchase an additional 1 million doses of its oral treatment for COVID-19.

Reuters · Dec 13, 2022

CSL names McKenzie as new CEO

COO Paul McKenzie will take over as CSL chief executive next year when Paul Perreault retires following a decade leading the blood products giant.

AAP · Dec 13, 2022

U.S. FDA approves Mirati's lung cancer drug

The U.S. Food and Drug Administration approved Mirati Therapeutics Inc's lung cancer drug adagrasib, the company said on Monday, sending its shares up more than 8% in extended trading.

Reuters · Dec 12, 2022

Glasgow push to tackle drug deaths crisis gets cross-party support

Councillors from all parties have agreed there must be more work done on helping people into recovery to cut the number of drug-related deaths.

Glasgow Live · Dec 12, 2022